Paul Mulholland

Has grant

Associate Professor

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paul Mulholland is an Associate Professor at University College London, UK. His research focuses on glioblastoma, particularly the therapeutic targeting of tumors and their microenvironment, as well as the use of novel imaging techniques to predict treatment responses. Recent publications include studies on dendritic cell vaccination approaches, survival outcomes, and the prognostic significance of DNA methylation in glioblastoma patients.

Recent Grants

Grant: Close

CRUKE/10/044: DORIC: Multi-centre, randomised, double-blind phase II study comparing cediranib (Recentin, AZD2171) plus gefitinib (Iressa, ZD1839) with cediranib plus placebo in subjects with recurrent/progressive glioblastoma

Open Date: 2010-10-01

Close Date: 2012-09-30

Articles (11)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Ahmed Idbaih

Sorbonne Université

FRANCE

View details

Kerry Chester

University College London

UNITED KINGDOM

View details

Quentin Pankhurst

University College London

UNITED KINGDOM

View details

Antoine F. Carpentier

FRANCE

View details

Jeremy G. Reynoso

University of California, Los Angeles

UNITED STATES

View details

Stefanie Thust

Clinical Associate Professor Neuroradiology

University of Nottingham

UNITED KINGDOM

View details

Robert Prins

Professor (with tenure)

Ronald Reagan UCLA Medical Center

UNITED STATES

View details

Rafael Torres Martin de Rosales

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul Mulholland

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Therapeutic Targeting of Glioblastoma and the Interactions with Its Microenvironment

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early.

Survival Outcomes and Prognostic Factors in Glioblastoma.

Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An International Randomized Phase 3 Trial.

Prognostic significance of DNA methylation profiles at MRI enhancing tumor recurrence: a report from the EORTC 26091 TAVAREC trial.

Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial

Longitudinal structural and perfusion MRI enhanced by machine learning outperforms standalone modalities and radiological expertise in high-grade glioma surveillance.

Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation.

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.

Collaborators (8)

Ahmed Idbaih

Kerry Chester

Quentin Pankhurst

Antoine F. Carpentier

Jeremy G. Reynoso

Stefanie Thust

Robert Prins

Rafael Torres Martin de Rosales

Make your next move.